nRNP Complex


SKU: SRC-3000

Available Now!

nRNP Complex antigen is a non-histone nuclear protein composed of several polypeptides of differing molecular weights. It has been shown that RNP and Sm are distinct antigenic sites on the same nuclear molecular matrix consisting of RNA and eight polypeptides, including 70 kD, A(33 kD), C(22 kD) and the Sm peptides B (26 kD), B'(27 kD), D(13 kD), E/F (11 kD doublet), and G (9 kD). Autoantibodies against the nRNP antigen precipitate the U1a and U1b small nuclear RNAs (2). The nRNP antigen is involved in normal post transcriptional, premessenger RNA processing to excise introns. (3) It has been demonstrated that the nRNP antigen is both RNase and tryptic digestion sensitive (4). Autoantibodies to the nRNP antigen, in high titers, have been strongly associated with patients who have Mixed Connective Tissue Disease (MCTD) (5). Other studies have shown that antibodies against the 70 kD polypeptide are found more frequently in sera of MCTD than in anti-nRNP positive SLE patients (6). It has been suggested that patients showing anti-nRNP antibodies tend to have some of the clinical features of MCTD, regardless of their overall disease diagnosis (7). Anti-nRNP antibodies only bind the U1 RNP while the anti-Sm binds with the U1 RNP, U2RNP, U4/6RNP, AND U5RNP. Anti-RNP antibodies are often accompanied by anti-Sm antibodies (1). Double immunodiffusion was the original method for detecting anti-nRNP. Passive hemagglutination was popularized later (8).

 Product Code:

Code Amount Price
1000 units


  1. Yasuma M, Takasaki Y Matsumoto K, et al: Clinical Significance of IgG Anti-Sm Antibodies in Patients with Systemic Lupus Erythematosus, The J of Rheumatology, 1990, pg 469-475.
  2. Lerner MR & Steitz JA: Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus: Proc natn Acad Sci, Vol 76, 1979, pg 5495-5499.
  3. Yang VW, Lerner MR, Steitz JA & Flint SJ: A small nuclear nbonucleoprotein is required for splicing of adenoviral early RNA sequences, Proc Natn Acad Sci, Vol 78, 1981, pg 1371-1375.
  4. Schrier WH, Reddy R and Busch H. Identification of an antigenic protein recognized by Anti-Sm autoantibody, Cell Biology International Reports, Vol 6, 1982, pg 925-932.
  5. Takeda Y Wang GS, Wang RJ, et al. Enzyme-Linked Immunosorbent Assay Using Isolated (U) Small Nuclear Ribonucleoprotein Polypeptides as Antigens to Investigate the Clinical Significance of Autoantibodies to these Polypeptides, Clinical Immunology and Immunopathology, Vol 50, 1989, pg 212-230.
  6. Habets WJ, de Rooij, DJ, Hoet MH, van de Putte LB, and van Venrooij WJ. Purification of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin Exp Immunol, Vol 59, 1985, pg 457-466.
  7. Rader MD, O’Brien C, Liu Y, Harley JB, and Reichlin M. Heterogeneity of the Ro/SSA Antigen. J Clin Invest, Vol 83, 1989, pg 1293-1298.
  8. Holman HR. Partial purification and characterization of an extractable nuclear antigen which reacts with SLE sera. Ann NY Acad Sci, Vol 124, 1965, pg 800-806.


Certificate of Analysis: